Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (6 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
2 selected
)
Type
Guidance (219)
Quality standard (0)
Guidance programme
(
3 selected
)
Guidance programme
Antimicrobial prescribing guidelines (2)
Clinical guidelines (45)
Diagnostics guidance (6)
Health technology evaluations (3)
Highly specialised technologies guidance (8)
Interventional procedures guidance (63)
Medical technologies guidance (27)
NICE guidelines (57)
Public health guidelines (7)
Social care guidelines (9)
Technology appraisal guidance (186)
Apply filters
Showing 21 to 30 of 219
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2021 and 31/3/2023
Remove Last updated date between 1/4/2021 and 31/3/2023 filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma
TA858
11 January 2023
11 January 2023
Upadacitinib for treating moderately to severely active ulcerative colitis
TA856
4 January 2023
4 January 2023
Avatrombopag for treating primary chronic immune thrombocytopenia
TA853
15 December 2022
15 December 2022
Cabozantinib for previously treated advanced hepatocellular carcinoma
TA849
14 December 2022
14 December 2022
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy
TA850
14 December 2022
14 December 2022
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer
TA851
14 December 2022
14 December 2022
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatments
TA852
14 December 2022
14 December 2022
Esketamine nasal spray for treatment-resistant depression
TA854
14 December 2022
14 December 2022
Memokath 051 Ureter stent for ureteric obstruction
MTG75
7 December 2022
7 December 2022
Cemiplimab for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal)
TA848
1 December 2022
1 December 2022
Previous page
1
2
Current page
3
4
5
…
22
Page
3
of
22
Next page
Results per page
10
25
50
All
Back to top